MedTrace Logo

Improving Autism Screening With Brain-Related miRNA

NCT02712853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 304

Last updated 2018-08-22

No results posted yet for this study

Summary

The goal of this project is to identify specific miRNAs that are increased or decreased in the saliva of children with developmental delay and are useful for screening toddlers for ASD. Such a screening tool would improve the specificity of diagnosis, streamline referrals to developmental specialists, and expedite the arrangement of early intervention services.

Conditions

Interventions

OTHER

Saliva collection

Collection of saliva via swab for miRNA processing

OTHER

Vineland Adaptive Behavior Scale-II Assessment

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Steven Hicks, MD, PhD · Milton S. Hershey Medical Center

Eligibility

Min Age
18 Months
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02712853 on ClinicalTrials.gov